Pan European Collaboration on Antipsychotic Naive Schizophrenia (PECANS) (PECANS)
Schizophrenia
About this trial
This is an interventional diagnostic trial for Schizophrenia focused on measuring dopamine, first episode, reward, cognition, MRI, fMRI, PPI, P300, P50 gating, endophenotypes
Eligibility Criteria
Inclusion Criteria:
For patients: meeting diagnostic criteria for schizophrenia according to ICD 10 or DSM IV antipsychotic naive The controls will be matched to the patients according to gender age and parental socio-economic status.
-
Exclusion Criteria:
Patients: mental retardation, other chronic diseases, use of antidepressive medicine during the last month,being pregnant, on going substance abuse
Controls: psychiatric diagnosis, psychiatric diagnosis in first-degree relatives,on going drug abuse, mental retardation -
Sites / Locations
- Center for Neuropsychiatric Schizophrenia Research, University of Copenhagen, Psychiatric Center Glostrup
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
first choice treatment
second choice treatment
Treatment with amisulpride
treatment with aripiprazole